- Home
- RVMD vs PDI Comparison
RVMD vs PDI Comparison
Compare RVMD & PDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- PDI
- Stock Information
- Founded
- RVMD 2014
- PDI 2012
- Country
- RVMD United States
- PDI United States
- Employees
- RVMD N/A
- PDI N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- PDI Trusts Except Educational Religious and Charitable
- Sector
- RVMD Health Care
- PDI Finance
- Exchange
- RVMD Nasdaq
- PDI Nasdaq
- Market Cap
- RVMD 7.5B
- PDI 7.1B
- IPO Year
- RVMD 2020
- PDI N/A
- Fundamental
- Price
- RVMD $65.84
- PDI $18.40
- Analyst Decision
- RVMD Strong Buy
- PDI
- Analyst Count
- RVMD 17
- PDI 0
- Target Price
- RVMD $77.24
- PDI N/A
- AVG Volume (30 Days)
- RVMD 2.4M
- PDI 1.5M
- Earning Date
- RVMD 11-05-2025
- PDI 01-01-0001
- Dividend Yield
- RVMD N/A
- PDI 13.81%
- EPS Growth
- RVMD N/A
- PDI N/A
- EPS
- RVMD N/A
- PDI N/A
- Revenue
- RVMD N/A
- PDI N/A
- Revenue This Year
- RVMD N/A
- PDI N/A
- Revenue Next Year
- RVMD $537.73
- PDI N/A
- P/E Ratio
- RVMD N/A
- PDI N/A
- Revenue Growth
- RVMD N/A
- PDI N/A
- 52 Week Low
- RVMD $29.17
- PDI $15.45
- 52 Week High
- RVMD $65.98
- PDI $19.60
- Technical
- Relative Strength Index (RSI)
- RVMD 84.78
- PDI 39.15
- Support Level
- RVMD $58.91
- PDI $18.07
- Resistance Level
- RVMD $63.15
- PDI $18.52
- Average True Range (ATR)
- RVMD 2.19
- PDI 0.20
- MACD
- RVMD 0.40
- PDI 0.05
- Stochastic Oscillator
- RVMD 98.46
- PDI 53.94
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About PDI PIMCO Dynamic Income Fund
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.